THE SUSTAINED VIROLOGICAL RESPONSE AS MARKER OF IMMUNOLOGICAL COMPLICATIONS ASSOCIATED WITH TREATMENT COMBINED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
Barra-Valencia, Vanessa [1 ]
Gimeno Calvo, Alberto [1 ]
Perez-Saborido, Baltasar [1 ]
Fernandez, Inmaculada [3 ]
Colina Ruizdelgado, Francisco [2 ]
Fundora Suarez, Yilliam [1 ]
Meneu Diaz, Juan Carlos [1 ]
Olivares Pizarro, Sergio Pedro [1 ]
Justo Alonso, Iago [1 ]
Abradelo de Usera, Manuel [1 ]
Jimenez Romero, Carlos [1 ]
Moreno Gonzalez, Enrique [1 ]
机构：
[1] Doce Octubre Univ Hosp, Dept Surg & Abdominal Organs Transplantat, Madrid, Spain
[2] Doce Octubre Univ Hosp, Dept Pathol, Madrid, Spain
[3] Doce Octubre Univ Hosp, Dept Gastroenterol, Madrid, Spain
来源：
TRANSPLANT INTERNATIONAL | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [1] FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
    Gentili, F.
    Grieco, S.
    Giusto, M.
    Loria, I.
    Rossi, M.
    Berloco, P.
    Novelli, G.
    Mennini, G.
    Corradini, S. Ginanni
    Attili, A. F.
    Merli, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S115 - S115
  • [2] High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation
    Nabiha Faisal
    Khalid Mumtaz
    Max Marquez
    Eberhard L. Renner
    Leslie B. Lilly
    [J]. Hepatology International, 2015, 9 : 76 - 83
  • [3] High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation
    Faisal, Nabiha
    Mumtaz, Khalid
    Marquez, Max
    Renner, Eberhard L.
    Lilly, Leslie B.
    [J]. HEPATOLOGY INTERNATIONAL, 2015, 9 (01) : 76 - 83
  • [4] Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin.
    Samuel, D
    [J]. HEPATOLOGY, 2003, 38 (04) : 531A - 531A
  • [5] Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation
    Dinges, S.
    Morard, I.
    Heim, M.
    Dufour, J.-F.
    Mullhaupt, B.
    Giostra, E.
    Clavien, P. -A.
    Mentha, G.
    Negro, F.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (01) : 33 - 39
  • [6] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
  • [7] Immunological and virological effects of ribavirin in hepatitis C after liver transplantation
    Quadri, R
    Giostra, E
    Roskams, T
    Pawlotsky, JM
    Mentha, G
    Rubbia-Brandt, L
    Perrin, L
    Hadengue, A
    Negro, F
    [J]. TRANSPLANTATION, 2002, 73 (03) : 373 - 378
  • [8] Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
    Cicinnati, V. R.
    Iacob, S.
    Klein, C. G.
    Baba, H. A.
    Sotiropoulos, G. C.
    Hilgard, P.
    Erim, Y.
    Broelsch, C. E.
    Gerken, G.
    Beckebaum, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) : 291 - 303
  • [9] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [10] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
12345